Related Experiment Video
Updated: Oct 21, 2025

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan
Sucharu Asri1, Muhammad Rizwan Akram2, Mohammad Mehedi Hasan3
1Faculty of Medicine and Health Sciences (FMHS), Shree Guru Gobind Singh Tricentenary Medical College, Haryana, India.
Abstract:
As a developing country, Pakistan reports a high burden of fungal diseases, of which cutaneous mucormycosis remains a prominent infection, presenting as a highly invasive disease with significant mortality. Apart from a high population of at-risk individuals, multiple factors have precipitated an increment in mucormycosis cases in the country following the COVID-19 pandemic. These include increased use of corticosteroids, immunosuppression following the viral infection, prolonged stays in the intensive care unit and sub-optimal laboratory testing available in the country. This article aims to assess the potential implications of a mucormycosis epidemic on a healthcare system already strained under the COVID-19 pandemic, and provides subsequent recommendations to weather the dual challenge of two deadly pathogens.
Insights
Pakistan faces a surge in mucormycosis fungal infections, particularly cutaneous mucormycosis, following COVID-19. This invasive disease poses a significant mortality risk, straining healthcare systems already burdened by the pandemic.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Public Health
Background:
- Pakistan experiences a high incidence of fungal infections, with cutaneous mucormycosis being a severe, invasive disease.
- The COVID-19 pandemic exacerbated mucormycosis cases due to increased corticosteroid use, viral-induced immunosuppression, prolonged ICU stays, and inadequate laboratory diagnostics.
Discussion:
- The concurrent rise of mucormycosis and COVID-19 presents a dual threat to Pakistan's healthcare infrastructure.
- Limited resources and diagnostic capabilities hinder effective management of these opportunistic fungal infections.
Key Insights:
- Cutaneous mucormycosis is a critical health concern in Pakistan, with post-COVID-19 trends indicating an epidemic.
- Factors contributing to the mucormycosis surge include compromised immunity and suboptimal healthcare conditions.
Outlook:
- Urgent strategies are needed to address the rising burden of mucormycosis amidst the ongoing COVID-19 pandemic.
- Strengthening diagnostic services and implementing targeted public health interventions are crucial for managing this dual pathogen challenge.
More Related Videos
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Fungal Group Zygomycota
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Fungal Phylum Microsporidia

